Zuzanna Mielewczyk

Research Associate

Focal points
  • Spatial proteomics, immunoassays
  • Molecular and protein chemical analyses
  • Cell culture
  • Laboratory management
  • Occupational safety officer

since 2026 Research associate at the Institute of Neuropathology at Ulm University Hospital

2023 to 2025 Research Associate at the Institute of Pathology and Molecular Diagnostics at Augsburg University Hospital, Department of Neuropathology

2021 to 2022 Scientific employee in molecular biology, Tentamus Pharma & Med Deutschland GmbH Karlsruhe

2017 to 2021 Associate Scientist R&D, LEUKOCARE AG Munich

2012 to 2017 Research Associate, MicroMol GmbH Karlsruhe

2006 to 2011 Study of Biotechnology, Gdansk University of Technology

Liesche-Starnecker F, Mielewczyk Z, Grochowski P, Jungbäck N, Adam P, Märkl B, Schlegel J. Hirnsektion in der Allgemeinpathologie. Pathologie (2026).doi: 10.1007/s00292-026-01543-0.

Here you will find selected publications before 2026. All publications can be found at PubMed.

Shiban E, Krauss P, Schaller T, Konietzko I, Mögele T, Jungbäck N, Mielke D, Märkl B, Kahl KH, Mielewczyk Z, Liesche-Starnecker F. A prospective observational study of inflammatory mediators in cerebrospinal fluid after intraoperative radiotherapy of brain tumors. Ther Adv Med Oncol. 17 (2025). doi: 10.1177/17588359251389740. PMID: 41262211. PMCID: PMC12623645.